HU0201262D0 - - Google Patents
Info
- Publication number
- HU0201262D0 HU0201262D0 HU0201262A HUP0201262A HU0201262D0 HU 0201262 D0 HU0201262 D0 HU 0201262D0 HU 0201262 A HU0201262 A HU 0201262A HU P0201262 A HUP0201262 A HU P0201262A HU 0201262 D0 HU0201262 D0 HU 0201262D0
- Authority
- HU
- Hungary
- Prior art keywords
- halogen
- preparing
- hydrogen
- compound
- formula
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12567199P | 1999-03-22 | 1999-03-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0201262D0 true HU0201262D0 (enExample) | 2002-05-29 |
| HUP0201262A2 HUP0201262A2 (en) | 2002-08-28 |
| HUP0201262A3 HUP0201262A3 (en) | 2003-12-29 |
Family
ID=22420863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201262A HUP0201262A3 (en) | 1999-03-22 | 2000-03-21 | Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6515130B1 (enExample) |
| EP (1) | EP1165543B1 (enExample) |
| JP (1) | JP2002540108A (enExample) |
| KR (1) | KR20020019895A (enExample) |
| CN (1) | CN1351600A (enExample) |
| AT (1) | ATE242235T1 (enExample) |
| AU (1) | AU775413B2 (enExample) |
| BR (1) | BR0010652A (enExample) |
| CA (1) | CA2368024A1 (enExample) |
| CZ (1) | CZ20013431A3 (enExample) |
| DE (1) | DE60003169T2 (enExample) |
| DK (1) | DK1165543T3 (enExample) |
| ES (1) | ES2199805T3 (enExample) |
| HK (1) | HK1046272A1 (enExample) |
| HR (1) | HRP20010767A2 (enExample) |
| HU (1) | HUP0201262A3 (enExample) |
| MX (1) | MXPA01009615A (enExample) |
| PT (1) | PT1165543E (enExample) |
| SK (1) | SK13562001A3 (enExample) |
| UA (1) | UA67832C2 (enExample) |
| WO (1) | WO2000056730A1 (enExample) |
| YU (1) | YU74601A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0201263A3 (en) | 1999-03-22 | 2003-05-28 | Ortho Mcneil Pharm Inc | Synthesis of 3-amino-3-aryl propanoates and intermediates |
| NZ531243A (en) * | 2001-09-21 | 2006-08-31 | Sanofi Aventis | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| EP2744802B1 (en) | 2011-08-17 | 2017-01-04 | Piramal Imaging SA | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| WO2014124943A1 (en) | 2013-02-12 | 2014-08-21 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| EP4289819A3 (en) | 2013-02-20 | 2024-01-10 | Reuter Chemische Apparatebau e.K. | Process for the preparation of enantiomerically enriched 3-aminopiperidine |
| WO2014173855A1 (en) | 2013-04-22 | 2014-10-30 | Reuter Chemische Apparatebau Kg | Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58243B1 (en) | 1983-12-07 | 1993-08-11 | Lonza Ag | A process for the preparation of optically-active 3-amino carboxylic acids |
| US5254573A (en) | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| CN1041919C (zh) * | 1993-09-22 | 1999-02-03 | 藤泽药品工业株式会社 | 用作血小板激活因子拮抗物的N-(3-哌啶基碳酰)-β-氨基丙酸衍生物 |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
| CA2248809A1 (en) * | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| DE69739239D1 (de) * | 1996-05-01 | 2009-03-19 | Ortho Mcneil Pharm Inc | Carboxamidderivate von Pyrrolidin, Piperidin und Hexahydropiperizin für Behandlung von Thrombosen |
| ES2167758T3 (es) | 1996-07-12 | 2002-05-16 | Searle & Co | Sintesis asimetrica de beta-aminoacidos quirales. |
| US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
-
2000
- 2000-03-21 ES ES00916573T patent/ES2199805T3/es not_active Expired - Lifetime
- 2000-03-21 EP EP00916573A patent/EP1165543B1/en not_active Expired - Lifetime
- 2000-03-21 CA CA002368024A patent/CA2368024A1/en not_active Abandoned
- 2000-03-21 JP JP2000606591A patent/JP2002540108A/ja active Pending
- 2000-03-21 DK DK00916573T patent/DK1165543T3/da active
- 2000-03-21 HU HU0201262A patent/HUP0201262A3/hu unknown
- 2000-03-21 US US09/532,375 patent/US6515130B1/en not_active Expired - Lifetime
- 2000-03-21 CZ CZ20013431A patent/CZ20013431A3/cs unknown
- 2000-03-21 YU YU74601A patent/YU74601A/sh unknown
- 2000-03-21 MX MXPA01009615A patent/MXPA01009615A/es unknown
- 2000-03-21 BR BR0010652-6A patent/BR0010652A/pt not_active IP Right Cessation
- 2000-03-21 WO PCT/US2000/007462 patent/WO2000056730A1/en not_active Ceased
- 2000-03-21 HR HR20010767A patent/HRP20010767A2/hr not_active Application Discontinuation
- 2000-03-21 CN CN00807617A patent/CN1351600A/zh active Pending
- 2000-03-21 DE DE60003169T patent/DE60003169T2/de not_active Expired - Fee Related
- 2000-03-21 AT AT00916573T patent/ATE242235T1/de not_active IP Right Cessation
- 2000-03-21 KR KR1020017012100A patent/KR20020019895A/ko not_active Withdrawn
- 2000-03-21 AU AU37661/00A patent/AU775413B2/en not_active Ceased
- 2000-03-21 UA UA2001096538A patent/UA67832C2/uk unknown
- 2000-03-21 PT PT00916573T patent/PT1165543E/pt unknown
- 2000-03-21 SK SK1356-2001A patent/SK13562001A3/sk unknown
- 2000-03-21 HK HK02107463.1A patent/HK1046272A1/zh unknown
-
2002
- 2002-02-22 US US10/081,289 patent/US20020137937A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0010652A (pt) | 2002-07-16 |
| HRP20010767A2 (en) | 2002-12-31 |
| SK13562001A3 (sk) | 2002-08-06 |
| DE60003169T2 (de) | 2005-10-27 |
| CN1351600A (zh) | 2002-05-29 |
| KR20020019895A (ko) | 2002-03-13 |
| DK1165543T3 (da) | 2003-09-29 |
| CA2368024A1 (en) | 2000-09-28 |
| JP2002540108A (ja) | 2002-11-26 |
| ATE242235T1 (de) | 2003-06-15 |
| AU775413B2 (en) | 2004-07-29 |
| DE60003169D1 (de) | 2003-07-10 |
| US20020137937A1 (en) | 2002-09-26 |
| EP1165543A1 (en) | 2002-01-02 |
| UA67832C2 (uk) | 2004-07-15 |
| WO2000056730A1 (en) | 2000-09-28 |
| MXPA01009615A (es) | 2003-07-21 |
| PT1165543E (pt) | 2003-10-31 |
| EP1165543B1 (en) | 2003-06-04 |
| YU74601A (sh) | 2004-05-12 |
| US6515130B1 (en) | 2003-02-04 |
| HUP0201262A3 (en) | 2003-12-29 |
| HK1046272A1 (zh) | 2003-01-03 |
| ES2199805T3 (es) | 2004-03-01 |
| AU3766100A (en) | 2000-10-09 |
| HUP0201262A2 (en) | 2002-08-28 |
| CZ20013431A3 (cs) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106743T1 (el) | Μεθοδος παρασκευης θειαμεθοξαμης | |
| NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
| CY1107635T1 (el) | Μεθοδος για την παρασκευη σιταλοπραμης | |
| MX9800412A (es) | Preparacion de 3-hidroxipirazoles n-substituidos. | |
| HU0201262D0 (enExample) | ||
| BG105766A (en) | New process for preparing pesticidal intermediates | |
| IN187760B (enExample) | ||
| BG106002A (en) | Process for preparing pesticidal intermediates | |
| IL146811A0 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
| MY130488A (en) | Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols | |
| PL367114A1 (en) | Process for preparing a thialzole ppar-ligand and polymorphs thereof | |
| WO2004009585A3 (fr) | Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp | |
| MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
| GB9920959D0 (en) | Novel process | |
| AU2001293791A1 (en) | Process for the preparation of vitronectin receptor antagonists | |
| ZA200005110B (en) | Process for preparing intermediates. | |
| TNSN01117A1 (en) | Process for preparing 2- (4-pyridyl) amino -6- dialkyloxyphenyl-pyrido [2,3 -d] pyrimidin-7-ones | |
| MY133207A (en) | Substituted benzolactam compaunds | |
| NZ284474A (en) | Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| GB9906328D0 (en) | 2-Substituted RNA preparation | |
| MY120806A (en) | Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives. | |
| ZA200208986B (en) | Process for the preparation of pesticidal compounds. | |
| TW358809B (en) | Phenylamidinothiophene compound and anti-inflammatory agent containing the same | |
| YU23301A (sh) | Postupak za dobijanje supstituisanih piridina | |
| WO1999011621A3 (en) | Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents |